Atlas Trials

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

Clinical trial NCT03518034 · COMPLETED

Trial details

NCT number
NCT03518034
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HypogonadismCardiovascular Diseases
Start date
2018-05-03
Primary completion
2023-01-19
Enrollment
5246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.